Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

Srinivasan R, Phillips JJ, Vandenberg SR, Polley MY, Bourne G, Au A, Pirzkall A, Cha S, Chang SM, Nelson SJ.

Neuro Oncol. 2010 Nov;12(11):1152-61. doi: 10.1093/neuonc/noq075. Epub 2010 Jul 20.

2.

The role of MR spectroscopy in neurooncology.

Kozić D, Ostojić J, Bjelan M, Koprivšek K.

Prilozi. 2012;33(1):425-33. Review.

PMID:
23037188
3.

Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.

Bader A, Heran M, Dunham C, Steinbok P.

J Neurosurg Pediatr. 2015 Aug;16(2):119-25. doi: 10.3171/2014.10.PEDS13634. Epub 2015 May 8. Review.

PMID:
25955808
4.

Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi O, Rosen B.

Cancer Res. 2014 Sep 1;74(17):4622-4637. doi: 10.1158/0008-5472.CAN-14-0383. Review.

5.

Diagnostic markers for glioblastoma.

Jung CS, Unterberg AW, Hartmann C.

Histol Histopathol. 2011 Oct;26(10):1327-41. doi: 10.14670/HH-26.1327. Review.

PMID:
21870336
6.

Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.

Subhawong TK, Wang X, Durand DJ, Jacobs MA, Carrino JA, Machado AJ, Fayad LM.

AJR Am J Roentgenol. 2012 Jan;198(1):162-72. doi: 10.2214/AJR.11.6505. Review.

Supplemental Content

Support Center